| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Use of somatostatin analog in management of carcinoid syndrome. | Dig Dis Sci | 1989 | 1.08 |
| 2 | Somatostatinomas, PPomas, neurotensinomas. | Semin Oncol | 1987 | 1.01 |
| 3 | Disseminated brown tumors from hyperparathyroidism masquerading as metastatic cancer: a complication of parathyroid carcinoma. | Am Surg | 2001 | 0.99 |
| 4 | Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management. | Acta Oncol | 1989 | 0.98 |
| 5 | Treatment of endocrine tumors of the pancreas. | Endocrinol Metab Clin North Am | 1989 | 0.87 |
| 6 | Distinguishing features of idiopathic flushing and carcinoid syndrome. | Arch Intern Med | 1988 | 0.80 |
| 7 | Transhepatic portal vein catheterization for localization of sporadic and MEN gastrinomas: a ten-year experience. | Surgery | 1990 | 0.80 |
| 8 | Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes. | Am J Med | 1986 | 0.78 |
| 9 | Somatostatin analogue (SMS 201-995) in patients with gastrinomas. | Surgery | 1988 | 0.76 |